CG
REGN icon

Cutler Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Cutler Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,000
Closed -$33K – 5065
2022
Q3 		$33K Sell
1,000
-1,400
-58% -$881K ﹤0.01% 2221
2022
Q2 		$46K Buy
2,400
+200
+9% +$130K ﹤0.01% 2005
2022
Q1 		$12K Buy
+2,200
New +$1.39M ﹤0.01% 3484
2019
Q1 		– Sell
-6,200
Closed -$70K – 4628
2018
Q4 		$70K Buy
6,200
+1,000
+19% +$366K 0.01% 1278
2018
Q3 		$58K Hold
5,200
– – ﹤0.01% 1516
2018
Q2 		$177K Sell
5,200
-800
-13% -$250K 0.01% 836
2018
Q1 		$206K Sell
6,000
-23,100
-79% -$8.03M 0.02% 810
2017
Q4 		$664K Sell
29,100
-21,600
-43% -$8.75M 0.03% 440
2017
Q3 		$584K Buy
50,700
+5,300
+12% +$2.52M 0.02% 583
2017
Q2 		$465K Buy
45,400
+39,100
+621% +$17.1M 0.02% 732
2017
Q1 		$227K Buy
6,300
+4,000
+174% +$1.48M 0.01% 1092
2016
Q4 		$259K Sell
2,300
-800
-26% -$304K 0.01% 1112
2016
Q3 		$356K Hold
3,100
– – 0.02% 796
2016
Q2 		$491K Sell
3,100
-900
-23% -$347K 0.02% 601
2016
Q1 		$601K Sell
4,000
-1,800
-31% -$742K 0.04% 447
2015
Q4 		$81K Buy
+5,800
New +$3.14M ﹤0.01% 1970

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cutler Group's REGN Position: Q4 2022 in Review

Cutler Group sold out of Regeneron Pharmaceuticals (REGN) in Q4 2022, closing a stake of 700 shares — an estimated $482K sold.

Cutler Group first reported a position in REGN in Q4 2015 and held it in 13 quarters. The position peaked at $2.06M in Q4 2017. 1,159 funds tracked by Wall St. Rank hold REGN as of Q4 2022.

  • Cutler Group reported no remaining Regeneron Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 700 Regeneron Pharmaceuticals shares in Q4 2022, an estimated $482K.
  • Cutler Group first reported a position in Regeneron Pharmaceuticals in Q4 2015 and held it in 13 quarters.
  • Cutler Group's Regeneron Pharmaceuticals position peaked at $2.06M in Q4 2017.
  • 1,159 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.